U.S. Orthopedic Stem Cell Market to Grow 68% in 2009

Orthopedic Stem Cell Market to Reach $228 Million by 2014

VANCOUVER, April 7 /PRNewswire/ - According to a report by iData Research
(www.idataresearch.net), an international medical device and dental market
research firm, the U.S. market for stem cells used in orthopedic therapy will
grow to an estimated $228 million by 2014. Applications are currently focused
on spinal fusion surgery, mostly for arthritis, but will eventually expand to
include the fixation of traumatic fractures and the regeneration of worn joint
cartilage.
Since 2005, adult stem cell products have been commercially available for use
in spinal fusion surgery, the common treatment for arthritis and other bone
defects. More than 29,000 patients have benefited from orthopedic stem cell
therapy, which eliminates the pain and surgical complexity of traditional
procedures. The Obama administration's lifting of research restrictions has
renewed public interest in applications for embryonic stem cell therapies.
"The aging population will be the main driver for stem cell therapies, as it
is for the overall orthopedic marketplace," says Kamran Zamanian PhD., CEO of
iData, "The prevalence of osteoarthritis and degenerative joint disease will
increase in the near future, driving the market for stem cell therapies. Stem
cells are an advancement over traditional treatments because, unlike other
treatments, they can potentially regenerate healthy tissue."
According to the report, over 60% of adults over 64 suffer from
osteoarthritis. This implies an enormous future market for all orthopedic stem
cell applications. This market will grow as baby boomers age and embryonic
stem cell use increases. The report estimates a compound annual growth rate of
33% through 2014.
"Stem cell therapy in orthopedics is not only ahead of other medical
applications, such as cardiology and neurology," says Zamanian. "It is also
less socially contentious because it is based on adult stem cell lines,
side-stepping the political difficulties with embryonic research, and
increasing potential patient acceptance."

About iData Research

iData Research (www.idataresearch.net) is an international market research and
consulting group focused on providing market intelligence for the medical
device, dental and pharmaceutical industries in categories such as:
Orthopedics, Sports Medicine, Spine, Cardiovascular, CRM, Dental, Endoscopy,
Imaging, Ophthalmics, Patient Monitoring, Urology, Women's Health and more.
To learn more about iData's services, view this 3-minute Movie at:
www.idataresearch.net/discoveridata.html

SOURCE iData Research Inc.

Drew Gutschmidt, iData Research, (604) 266-6933, marketing@idataresearch.net